Fauna Bio: Gleaning Therapeutic Insights From Animals

In Vivo speaks with Ashley Zender, CEO of Fauna Bio, a company using AI to identify drug targets based on natural disease resistance in animals. The company's $494m partnership with Eli Lilly is a testament to the value of their approach.

Episode metadata supplied by the publisher feed · Published Jan 20, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Fauna Bio: Gleaning Therapeutic Insights From Animals

0:00 22:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 22 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on January 20, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!